APA (7th ed.) Citation

Frouws, M., Rademaker, E., Bastiaannet, E., van Herk-Sukel, M., Lemmens, V., Van de Velde, C., . . . Liefers, G. (2017). The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer. European Journal of Cancer, 77, 24. https://doi.org/10.1016/j.ejca.2017.02.025

Chicago Style (17th ed.) Citation

Frouws, M.A, E. Rademaker, E. Bastiaannet, M.P.P van Herk-Sukel, V.E Lemmens, C.J.H Van de Velde, J.E.A Portielje, and G.J Liefers. "The Difference in Association Between Aspirin Use and Other Thrombocyte Aggregation Inhibitors and Survival in Patients with Colorectal Cancer." European Journal of Cancer 77 (2017): 24. https://doi.org/10.1016/j.ejca.2017.02.025.

MLA (9th ed.) Citation

Frouws, M.A, et al. "The Difference in Association Between Aspirin Use and Other Thrombocyte Aggregation Inhibitors and Survival in Patients with Colorectal Cancer." European Journal of Cancer, vol. 77, 2017, p. 24, https://doi.org/10.1016/j.ejca.2017.02.025.